Rankings
▼
Calendar
AUPH FY 2025 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$283M
+20.4% YoY
Gross Profit
$250M
88.5% margin
Operating Income
$105M
37.1% margin
Net Income
$287M
101.5% margin
EPS (Diluted)
$2.07
Cash Flow
Operating Cash Flow
$136M
Free Cash Flow
$135M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$752M
Total Liabilities
$170M
Stockholders' Equity
$581M
Cash & Equivalents
$80M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$283M
$235M
+20.4%
Gross Profit
$250M
$207M
+21.0%
Operating Income
$105M
-$5M
+2338.4%
Net Income
$287M
$6M
+4893.1%
← Q4 2024
All Quarters
Q1 2025 →